aortic valve replacement

Sistema EVOQUE: reemplazo tricuspídeo transcatéter, resultados al año

Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis

A study by the Northern New England Cardiovascular Disease Group Consortium recently published online identified all patients with aortic valve stenosis treated with surgical or transcatheter aortic valve replacement between 2016 and 2022 in Maine, New Hampshire, and Vermont (USA). These patients were divided for analysis into three age groups: under 65 years old, 65<a href="https://solaci.org/en/2024/04/11/temporal-trends-in-transcatheter-aortic-valve-replacement-for-isolated-severe-aortic-stenosis/" title="Read more" >...</a>

revascularizacion incompleta en cirugia no cardiaca

Redo Surgical Aortic Valve Replacement after Prior Transcatheter vs Surgical Aortic Valve Replacement: A Growing Population

Transcatheter aortic valve replacement (TAVR) has evolved since it was first implemented, and it is now also used to treat low risk patients. One of the questions this has raised is whether patient life expectancy is higher than prosthesis life expectancy.&nbsp; The growing population in need for valve replacement also poses the question of how<a href="https://solaci.org/en/2023/05/08/redo-surgical-aortic-valve-replacement-after-prior-transcatheter-vs-surgical-aortic-valve-replacement-a-growing-population/" title="Read more" >...</a>

Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

Avatar Trial: Is It Time to Use Surgical Aortic Valve Replacement in Asymptomatic Patients?

It is still unclear whether surgical aortic valve replacement (SAVR) is beneficial in asymptomatic patients with severe aortic stenosis (AS) and conserved left ventricular function (C1 indication according to AHA guidelines). The European American guidelines only recommend intervention in asymptomatic patient when there is ventricular compromise (ejection fraction &lt;50%, class I indication) or with a<a href="https://solaci.org/en/2022/05/05/avatar-trial-is-it-time-to-use-surgical-aortic-valve-replacement-in-asymptomatic-patients/" title="Read more" >...</a>

Experiencia de la cirugía

TAVR vs Sutureless Surgical Aortic Valve Replacement in Low-Risk Patients

Sutureless surgical aortic valve replacement (SU-SAVR) has been designed to make surgical valve replacement easier and faster, especially compared against conventional biological valves which require multiple sutures; their rapid deployment translates into reduced cross-clamp and operative time. These valves shorten operating time and are less invasive than conventional surgical valves.&nbsp; Except for sternotomy incisions, they<a href="https://solaci.org/en/2021/11/19/tavr-vs-sutureless-surgical-aortic-valve-replacement-in-low-risk-patients/" title="Read more" >...</a>

TAVR-LM Registry: Transcatheter Aortic Valve Replacement and Left Main Stenting

Original Title: Outcomes in Patients with Transcatheter Aortic Valve Replacement and Left Main Stenting. The TAVR-LM Registry. Reference: TarunChakravarty et al. Journal of the American College of Cardiology, Vol 67, N° 8, 2016. Courtesy of Dr. Santiago F. Coroleu.  High surgical risk patients with severe aortic stenosis and significant left main aortic arterydiseaseare often treated combining<a href="https://solaci.org/en/2016/03/22/tavr-lm-registry-transcatheter-aortic-valve-replacement-and-left-main-stenting/" title="Read more" >...</a>

CLEAN-TAVI: transcatheter aortic valve replacement with cerebral protection

The stroke is a leading complication of post transcatheter aortic valve implantation increasing up to 3 times the mortality of these patients. In the works performed neuroimaging new post, TAVR defects were observed in two-thirds of patients and this increases the risk of post clinical stroke.&nbsp; There is a missing data in the literature of<a href="https://solaci.org/en/2015/06/24/congress-item-8253/" title="Read more" >...</a>

CoreValve superior to surgical aortic valve replacement in high-risk patients

The aim of this study was to compare percutaneous aortic valve replacement (TAVR) with the self-expanding Valve Core with conventional surgery in patients at high surgical risk. Patients with a valve area &lt; 0.8 cm2 , valvular index &le; 0.5 cm2 , a mean gradient of &nbsp;&gt; 40 mmHg or peak speeds above 4m /s<a href="https://solaci.org/en/2015/06/24/congress-item-7616/" title="Read more" >...</a>

REPRISE II: LOTUS valve for percutaneous aortic valve replacement

The aim of this study was to evaluate the safety and efficacy of the new device in patients with severe aortic stenosis at high surgical risk. We included 120 patients with a mean age of 84 years and the aortic valve area of 0.7 cm2. The device was successfully implanted in all patients with a<a href="https://solaci.org/en/2015/06/24/congress-item-6384/" title="Read more" >...</a>

Transcatheter Aortic Valve Replacement showed better results than conventional surgery in high risk diabetic patients.

Original title:&nbsp;Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).&nbsp;Reference:&nbsp;Lindman BR et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1090-9. Diabetes is associated to greater morbidity and mortality after surgical aortic valve replacement (SAVR),<a href="https://solaci.org/en/2014/03/26/n-4369/" title="Read more" >...</a>

Transcatheter Aortic Valve Replacement in patients with low ejection fraction: comparable outcomes with good ejection fraction patients.

Original title:&nbsp;Relation of Pre-procedural Assessment of Myocardial Contractility Reserve on Outcomes of Aortic Stenosis Patients with Impaired Left Ventricular Function Undergoing Transcatheter Aortic Valve Implantation&nbsp;Reference:&nbsp;Israel M. Barbash et al. Am J Cardiol. 2014, Epub ahead of print. &nbsp; Transcatheter aortic valve replacement (TAVI) is associated with a better left ventricular function (LV) in patients with<a href="https://solaci.org/en/2014/03/19/n-4355/" title="Read more" >...</a>

Top